Company Profile

Healionics Corporation
Profile last edited on: 12/10/19      CAGE: 4TB23      UEI: KS25PLAKN3X3

Business Identifier: Engineered biomaterials that enhance tissue integration and infection control: improved vascular access for dialysis patients
Year Founded
2007
First Award
2009
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2121 North 35th Street Suite 200
Seattle, WA 98103
   (206) 432-9060
   info@healionics.com
   www.healionics.com
Location: Single
Congr. District: 07
County: King

Public Profile

Healionics Corporation is a biomaterials company organized around addressng the needs of firm involved tissue regeneration and device biointegration. The firm offers sphere templated angiogenic regeneration (STAR) technology, which provides substrate independent, precision engineered, and 3D biomaterial scaffolds that enhance the bio-integration and promote healing of implanted medical devices. Haelionic's products are used in various areas, including wound care, aesthetic medicine, cardiovascular surgery, diabetes, general surgery, ophthalmology, pain management, regenerative medicine, and urological/women's health. Healionics personnel are applying the firm's expertise in synthetic biomaterials to develop a novel vascular graft (artificial blood vessel) that, unlike existing grafts, remains open to blood flow long-term without need for costly interventions. The firm's first commercial application will be as a more reliable means of vascular access for dialysis patients, with a subsequent application to treat peripheral artery disease. Quality results have been achived in multiple controlled animal studies; the firm has a large patent portfolio; has established production capacity, and are ready to begin human studies in preparation for market launch

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Mike Connolly -- CEO

  Max Maginness -- Founder, President and COO

  Michel Alvarez -- Founder, Chairman and Chief Executive Officer

  Arthur Coury -- Director

  Andrew Marshall -- Founder, Director and Chief Technology Officer

  Buddy Ratner -- Founder and Director